Suppr超能文献

神经退行性疾病的进展

Advances in Neurodegenerative Diseases.

作者信息

Van Schependom Jeroen, D'haeseleer Miguel

机构信息

Center for Neurosciences, NEUR and AIMS Research Groups, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussel, Belgium.

Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium.

出版信息

J Clin Med. 2023 Feb 21;12(5):1709. doi: 10.3390/jcm12051709.

Abstract

Neurological disorders are the leading cause of physical and cognitive disability across the globe, currently affecting approximately 15% of the worldwide population [...].

摘要

神经疾病是全球身体和认知残疾的主要原因,目前影响着全球约15%的人口[……]。

相似文献

1
Advances in Neurodegenerative Diseases.
J Clin Med. 2023 Feb 21;12(5):1709. doi: 10.3390/jcm12051709.
2
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.
Lancet. 1997 May 17;349(9063):1436-42. doi: 10.1016/S0140-6736(96)07495-8.
3
The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017.
Lancet Public Health. 2020 Oct;5(10):e551-e567. doi: 10.1016/S2468-2667(20)30190-0.
4
Do patients diagnosed with a neurological disease present increased risk of suicide?
Neurologia (Engl Ed). 2023 Jan-Feb;38(1):41-46. doi: 10.1016/j.nrleng.2020.03.005. Epub 2022 Sep 24.
5
The Potential of Proteomics in Understanding Neurodegeneration.
Int Rev Neurobiol. 2015;121:25-58. doi: 10.1016/bs.irn.2015.05.002. Epub 2015 Jun 19.
6
Current and Future Nano-Carrier-Based Approaches in the Treatment of Alzheimer's Disease.
Brain Sci. 2023 Jan 27;13(2):213. doi: 10.3390/brainsci13020213.
7
Dental stem cells as a promising source for cell therapies in neurological diseases.
Crit Rev Clin Lab Sci. 2019 May;56(3):170-181. doi: 10.1080/10408363.2019.1571478. Epub 2019 Apr 1.
8
Extracellular vesicles: A new paradigm in understanding, diagnosing and treating neurodegenerative disease.
Front Aging Neurosci. 2022 Nov 3;14:967231. doi: 10.3389/fnagi.2022.967231. eCollection 2022.
9
Preventive and Therapeutic Potential of Physical Exercise in Neurodegenerative Diseases.
Antioxid Redox Signal. 2021 Mar 10;34(8):674-693. doi: 10.1089/ars.2020.8075. Epub 2020 Apr 24.

引用本文的文献

1
CRISPR in Neurodegenerative Diseases Treatment: An Alternative Approach to Current Therapies.
Genes (Basel). 2025 Jul 22;16(8):850. doi: 10.3390/genes16080850.
3
Multifunctional gold nanoclusters as next-generation theranostic platforms for disease management.
Int J Pharm X. 2025 Jul 21;10:100361. doi: 10.1016/j.ijpx.2025.100361. eCollection 2025 Dec.
7
Public hesitancy for AI-based detection of neurodegenerative diseases in France.
Sci Rep. 2025 Jul 23;15(1):26849. doi: 10.1038/s41598-025-11917-8.
8
Polyphenols in the Central Nervous System: Cellular Effects and Liposomal Delivery Approaches.
Int J Mol Sci. 2025 Jul 4;26(13):6477. doi: 10.3390/ijms26136477.
9
Editorial: Innovative therapies against neurodegenerative disorders: from new active molecules to novel drug delivery systems.
Front Pharmacol. 2025 Jun 25;16:1640758. doi: 10.3389/fphar.2025.1640758. eCollection 2025.
10
The rise of 3D bioprinting advancements in modeling neurodegenerative diseases.
Ibrain. 2025 Apr 22;11(2):259-267. doi: 10.1002/ibra.12196. eCollection 2025 Summer.

本文引用的文献

1
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study.
Nat Med. 2023 Jan;29(1):75-85. doi: 10.1038/s41591-022-02097-3. Epub 2023 Jan 9.
3
Microglia regulate central nervous system myelin growth and integrity.
Nature. 2023 Jan;613(7942):120-129. doi: 10.1038/s41586-022-05534-y. Epub 2022 Dec 14.
4
Artificial intelligence will change MS care within the next 10 years: No.
Mult Scler. 2022 Dec;28(14):2173-2174. doi: 10.1177/13524585221125376.
5
Artificial intelligence will change MS care within the next 10 years: Yes.
Mult Scler. 2022 Dec;28(14):2171-2173. doi: 10.1177/13524585221130421.
6
Epidemiology and Pathophysiology of Multiple Sclerosis.
Continuum (Minneap Minn). 2022 Aug 1;28(4):988-1005. doi: 10.1212/CON.0000000000001136.
7
Brain age as a surrogate marker for cognitive performance in multiple sclerosis.
Eur J Neurol. 2022 Oct;29(10):3039-3049. doi: 10.1111/ene.15473. Epub 2022 Jul 11.
8
Emerging therapies to target CNS pathophysiology in multiple sclerosis.
Nat Rev Neurol. 2022 Aug;18(8):466-475. doi: 10.1038/s41582-022-00675-0. Epub 2022 Jun 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验